Home >> Report Store >> Healthcare >> Next Generation Sequencing (NGS) Market, By Technology (Whole Exon Sequencing  >

Next Generation Sequencing (NGS) Market Size Worth $20.8 Billion By 2025 | CAGR: 9.1%

Published Date : 15 / 12 / 17 | Report Format: PDF

The global next generation sequencing (NGS) market is expected to grow at growth rate of 9.1% to reach USD 20.8 billion by 2025.

Next Generation Sequencing (NGS) is a technique that enables the sequencing of thousands of DNA molecules simultaneously. This technique has revolutionized the medical fields, in terms of the treatment of genetic diseases, use of personalized medicines and clinical diagnostic techniques. NGS technology is used for the wide range of sequencing approaches such as transcriptome, genome, and epigenome of any organism. Advancement in technologies has stimulated the uptake of NGS techniques among end-users, leading to driving the market growth. A significant advancement in NGS technology occurred with the introduction of paired-end (PE) sequencing technique. PE sequencing method involves sequencing of DNA fragments at both ends and enables to align the reverse and forward reads as reading pairs. Additionally, producing the twice reads and alignment of reverse and forward read pairs improve accuracy and ability to sequence effectively compared to the single read data. Such introduction is anticipated to stimulate the demand for NGS technologies, augmenting the market growth to great extent.

Companies such as Illumina, Inc., Qiagen, Agilent Technologies, Genomatix GmbH, and Roche are profiles in the study. Among which, Roche and Illumina Inc. accounted for the significant share of the total market. This is majorly attributed to their product offerings to the market of technologically advanced next-generation sequencing platforms such HiSeq and Miseq which are capable of rapidly sequencing whole genomes at relatively less expensive costs.

To access report highlight and table of content of this report, please click the link below:


Key Takeaways :

► Targeted sequencing captured significant share of the global market owing to the significant advantages of it compared to the traditional WGS study

► NGS technique has major applications in oncology wherein it is used to sequence and Catalogue gene mutations for further      development of novel cancer diagnostic and therapeutic methodologies, witnessing the significant increase in demand throughout the future period.

► NGS has emerged as an essential and important tool to understand the altered genetic pathways responsible for the development for cancer.

► The pre-sequencing segment covers products such as NGS library preparation kits, NGS semi-automated library preparation, and clonal amplification. This phase includes the sample preparation processes that are undertaken prior to the sequencing step. In 2017, this segment captured USD 1,345.9 million, growing at significant growth rate.

► Developing regions such as the Asia Pacific and Latin America is projected to grow with the strong growth rate. Growth of these countries is majorly attributed to the significant developments by China and Japan for technological integration of NGS  methodologies, and the development of healthcare, R&D, and clinical development frameworks


  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the competitive landscape of this market
  • In-depth analysis of the key factors are propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market grow

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation :


  • Whole Exon Sequencing (WES)
  • Whole Genome Sequencing (WGS)
  • Targeted Sequencing
  • Resequencing Technique


  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Consumer Genomics
  • Immune Monitoring
  • Others


  • Pre-Sequencing Products
  • Sequencing Services
  • Data Analysis


  • Academic Research
  • Hospital Settings
  • Clinical Laboratories
  • Others


  • North America
  • Europe
  • Asia Pacific
  • Rest of the World


  • Further Breakdown of The North America Market
    • U.S.
    • Canada
  • Further Breakdown of The Europe Market
    • Germany
    • France
    • Rest of Europe
  • Further Breakdown of The APAC Market
    • India
    • China
    • Rest of APAC
  • Further Breakdown of The Rest of the World Market
    • Middle East and Africa
    • Latin America

Why AnalystView?


Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.


Tailor-Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.


Data Accuracy and Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This